DXB 5.62% 42.0¢ dimerix limited

Both COVID trials have been a disaster from start to finish. So...

  1. 2,052 Posts.
    lightbulb Created with Sketch. 664
    Both COVID trials have been a disaster from start to finish. So many delays, way too long to get going, recruited a miserable amount of patients (i think CLARITY were aiming for 600 and recruited 49), trial paused and suspended, forever and a day to see any data. Yet REMAP CAP won trial of the year. Lol
    Last edited by BT6487: 15/09/22
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.